Medical / Clinical Discussions, page-2

You have to remember that my interest in RAC is not $ wise but rather to get the drug patient (I acknowledge that we need $ to get the drug out there).

Also, my interest is more in the treatment of blood cancers and so within the five path strategy, the pathways involving other cancers goes over my head.

Lastly, I am not a doctor and I rely on google for research (understand why people will stop reading here).

----------
MRD
https://en.wikipedia.org/wiki/Minimal_residual_disease

"In cancer treatment, particularly leukaemia, MRD testing has several important roles: determining whether treatment has eradicated the cancer or whether traces remain, comparing the efficacy of different treatments, monitoring patient remission status as well as detecting recurrence of the leukaemia or cancer, and choosing the treatment that will best meet those needs ."

- I always treated/understood MRD to be an indicator of how successful treatment was. Never really found any material to indicate that MRD is focused on separately than cancer being treated. I doubt myself research too much to say that RAC approach is new to MRD, but it appears to be new. At least it sounds to me, like a drug-specific for MRD regardless of the type of cancer. Would be interesting if Dr T / or others, more intelligent people can share their thoughts.

Ps. blood cancer is rising rapidly in the world -

https://www.adelaidenow.com.au/news/south-australia/report-shows-blood-cancers-on-track-to-double-in-15-years/news-story/74aa823e20a2064491a75048c784c6e3

It could be due to weedkillers?

https://www.theguardian.com/australia-news/2019/jun/02/roundup-cancer-link-australian-firms-consider-lawsuits-over-exposure-to-weedkiller


Interesting if you go and see a haematologist, it looks like a farming convention.